DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
George DJ, Michaelson MD, Rosenberg JE, Bukowski RM, Sosman JA, Stadler WM, Margolin K, Hutson TE, Rini BI.
Phase II trial of sunitinib in bevacizumab-refractory
metastatic renal cell carcinoma (mRCC): Updated results and analysis of
circulating biomarkers.
J Clin Oncol 2007; 25
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.